Is Bioceres Crop (NASDAQ:BIOX) valuation viable?


USD 13.81  0.44  3.29%   

While many traders are getting carried away by overanalyzing basic materials space, it is reasonable to break down Bioceres Crop Solutions. We are going to cover the possibilities of making Bioceres Crop into your portfolio. Is current the firm value sustainable? We will go over Bioceres Crop Solutions valuation drivers to give you a better outlook on taking a position in it.
Published over two months ago
View all stories for Bioceres Crop | View All Stories
The company currently holds 206.37 M in liabilities with Debt to Equity (D/E) ratio of 1.76, which is about average as compared to similar companies. Bioceres Crop Solutions has a current ratio of 1.14, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Bioceres Crop until it has trouble settling it off, either with new capital or with free cash flow. So, Bioceres Crop's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioceres Crop Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioceres to invest in growth at high rates of return. When we think about Bioceres Crop's use of debt, we should always consider it together with cash and equity.
Our trade advice tool can cross-verify current analyst consensus on Bioceres Crop Solutions and to analyze the company potential to grow in the current economic cycle.
We determine the current worth of Bioceres Crop Solutions using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bioceres Crop Solutions based exclusively on its fundamental and basic technical indicators. By analyzing Bioceres Crop's financials, quarterly and monthly indicators, and related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bioceres Crop's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioceres Crop. We calculate exposure to Bioceres Crop's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bioceres Crop's related companies.

Bioceres Crop Solutions Investment Alerts

Bioceres investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Bioceres Crop Solutions performance across your portfolios.Please check all investment alerts for Bioceres

Bioceres Crop Valuation Ratios as Compared to Competition

Our valuation model uses many indicators to compare Bioceres value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioceres Crop competition to find correlations between indicators driving the intrinsic value of Bioceres.

How does Bioceres utilize its cash?

To perform a cash flow analysis of Bioceres Crop, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Bioceres Crop is receiving and how much cash it distributes out in a given period. The Bioceres Crop cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

A Deeper look at Bioceres

The entity reported the previous year's revenue of 307.95 M. Net Loss for the year was (1.55 M) with profit before overhead, payroll, taxes, and interest of 90.29 M.
 2018 2019 2020 2022 (projected)
Current Assets98.21 M164.69 M211.49 M121.02 M
Total Assets242.47 M297.56 M394.59 M288.33 M

Margins Breakdown

Bioceres profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Bioceres Crop itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Bioceres Crop profit margins.
EBITDA Margin0.0379
Gross Margin0.36
Profit Margin(0.15)

Bioceres Crop Earnings before Tax is fairly stable at the moment. Bioceres Crop Average Assets is increasing over the last 6 years. The current value of Bioceres Crop Average Assets is 366,934,597. Furthermore, Bioceres Crop Earnings Before Interest Taxes and Depreciation Amortization EBITDA is fairly stable at the moment. Bioceres Crop Earnings before Tax is increasing over the last 8 years. Bioceres Crop Average Assets is increasing over the last 6 years. The previous year's value of Bioceres Crop Average Assets was 366,934,597. Furthermore, Bioceres Crop Earnings Before Interest Taxes and Depreciation Amortization EBITDA is fairly stable at the moment.

Is Bioceres Crop growth reliable after the slide?

Current semi variance is at 21.35. Bioceres Crop Solutions exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Bioceres Crop Solutions individually to make sure intended market timing strategies and available technical indicators are consistent with their estimates about Bioceres Crop future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bioceres Crop's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bioceres Crop's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Conclusion on Bioceres Crop

While many other companies in the agricultural inputs industry are either recovering or due for a correction, Bioceres may not be as strong as the others in terms of longer-term growth potentials. The inconsistency in the assessment between current Bioceres valuation and our trade advice on Bioceres Crop is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Bioceres Crop.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Bioceres Crop Solutions. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to